Savara Inc (SVRA) - Yalpi rentabellik

Savara Pharma (SVRA) kompaniyasining rasmiy ramzlari

Savara Inc. (SVRA) kamyob o'pka patologiyalariga qarshi kurashish uchun innovatsion inhalatorlar ishlab chiqqani sababli tibbiyot mutaxassislari tomonidan yuqori baholanadi. Rejalashtirilgan yalpi foyda operatsion tiklanish sur'atini ko'rsatadi, bunda joriy ko'rsatkich 0.00 ni tashkil etadi. Biroq, yagona dori vositasiga kuchli bog'liqlik binar xatarlarni yuzaga keltiradi, chunki FDA qarorlaridagi har qanday chetga chiqish yoki yakuniy testlardagi muvaffaqiyatsizlik aksiyalar narxining qulashiga sabab bo'lishi mumkin.

savarapharma.com (SVRA) Yalpi rentabellik: 04.07.2022 - 20.11.2026 davri uchun

Savara Inc. (SVRA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
Fundamental baholash:SVRA - Savara Inc
Savara Pharma ishlab chiqargan mahsulot

Yalpi foyda marjasi investitsiyalarning ishonchliligini aniqlovchi asosiy filtr vazifasini o'taydi va biznesning haqiqiy daromadliligini aniqlash uchun umumiy tushumdan sotilgan tovarlar tannarxini ayirish orqali ishlab chiqarish samaradorligini o'lchaydi. Yalpi foyda foizini tahlil qilish orqali investor Savara Inc. (SVRA) kompaniyasining kamyob komponentlar global ta'minot zanjiridagi uzilishlarga hamda xomashyo narxlari va farmatsevtika logistikasiga ta'sir qiluvchi geosiyosiy xavflarga nisbatan chidamliligini baholashi mumkin.

Asosiy raqobatchilar

argenx - Yalpi foyda normasi|Yalpi rentabellik biontech.de|ABIVAX (ABVX) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja ADMA|Yalpi foyda koeffitsiyenti PTGX|Yalpi rentabellik Immunovant Corp IMVT|Yalpi marja Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Yalpi foyda bo'yicha rentabellik|Aurinia Pharmaceuticals Inc. (AUPH) - Yalpi marja|Yalpi foyda bo'yicha rentabellik BCRX|Yalpi foyda marjasi Vera Therapeutics Inc VERA|Yalpi foyda bo'yicha rentabellik DNTH (Dianthus Pharma)|Yalpi foyda bo'yicha sotuv rentabelligi Pharvaris N.V.|AbCellera Biologics Inc - Yalpi foyda bo'yicha rentabellik|Tourmaline Bio (TRML) - Yalpi foyda marjasi|PGEN - Yalpi rentabellik|Yalpi foyda normasi PHAR (Pharming Group NV)|NKTR: Yalpi marja|Upstream Bio Corp - Yalpi foyda normasi|Yalpi rentabellik Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOSS|Yalpi foyda bo'yicha rentabellik KalVista Pharmaceuticals, Inc. KALV|Yalpi rentabellik Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Yalpi foyda marjasi|RIGL: Yalpi foyda bo'yicha rentabellik|ANAB - Yalpi marja|ATXS: Yalpi marja|ENGN - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi foyda bo'yicha rentabellik RAPT|JBIO (Aerovate Therapeutics Inc) - Yalpi foyda koeffitsiyenti|Yalpi marja ACRS|Yalpi foyda bo'yicha rentabellik kyvernatx.com KYTX|Yalpi marja TLSA (Tiziana Life Sciences, Ltd.)|Yalpi marja Cabaletta Bio CABA|VTYX: Yalpi foyda bo'yicha rentabellik|Theratechnologies Inc. (THTX) - Yalpi foyda bo'yicha rentabellik|AVTX: Yalpi marja|ELDN - Yalpi foyda bo'yicha sotuv rentabelligi|AGEN (Agenus, Inc) - Yalpi marja|Yalpi marja Climb Bio, Inc.|Yalpi rentabellik Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Yalpi foyda normasi|Yalpi marja ADAG (Adagene Inc)|IMA - Yalpi foyda bo'yicha rentabellik|STTK - Yalpi rentabellik|EQ (equilliumbio.com) - Sotuvning yalpi rentabelligi|CNTB: Yalpi marja|Immunic Inc (IMUX) - Yalpi marja|ATRA (Atara Biotherapeutics Inc) - Yalpi marja|Sotuvning yalpi rentabelligi IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Yalpi foyda normasi|Adicet Bio, Inc. - Sotuvning yalpi rentabelligi|Celularity Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja INmune Bio Corporation INMB|Barinthus Biotherapeutics - Yalpi marja|Kezar Life Sciences, Inc. (KZR) - Yalpi foyda bo'yicha rentabellik|SAB Biotherapeutics Inc. (SABS) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Akari Therapeutics plc|Yalpi rentabellik enlivex.com|q32bio.com (QTTB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOVX|Edesa Biotech, Inc. - Sotuvning yalpi rentabelligi|iBio Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja Carisma Therapeutics CARM|XTLB - Yalpi rentabellik|BOLT (boltbio.com) - Sotuvning yalpi rentabelligi|HCWB: Yalpi marja|Aptevo (APVO) - Yalpi marja|Yalpi rentabellik AIM ImmunoTech|Yalpi foyda bo'yicha rentabellik Aditxt (ADTX)|Yalpi foyda bo'yicha rentabellik GRI (GRI Bio Corporation)|XORTX - Sotuvning yalpi rentabelligi|Yalpi marja HIND (Vyome Holdings Inc.)|Yalpi foyda normasi REVB|Indaptus - Yalpi marja|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning yalpi rentabelligi|CALI: Yalpi marja|Affimed NV - Yalpi foyda normasi|Yalpi rentabellik Allakos Inc.|Yalpi marja HOOKIPA Pharma|Yalpi rentabellik IGM Biosciences, Inc. (IGMS)|ITOS - Yalpi foyda marjasi|Yalpi marja OCEA (Ocean Bio)|Yalpi foyda normasi TCBP|THRD - Yalpi rentabellik